BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7976360)

  • 1. [Study on mitoxantrone polycyanoacrylate nanospheres].
    Zhang ZR; Liao GT; Hou SX
    Yao Xue Xue Bao; 1994; 29(7):544-9. PubMed ID: 7976360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on pharmacokinetics of mitoxantrone polycyanoacrylate nanoparticles freeze-dried injection by HPLC column switching technique].
    Zhang ZR; Liao GT; Ye LM
    Yao Xue Xue Bao; 1995 Nov; 30(11):843-7. PubMed ID: 8712010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antitumor activity of mitoxantrone-nanosphere against murine liver tumor H22].
    Yang YX; Zhu L; He X; Bao DY; Bao X
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):68-70. PubMed ID: 14981819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on mitoxantrone albumin microspheres for liver targeting].
    Zhang ZR; Qian WJ
    Yao Xue Xue Bao; 1997; 32(1):72-8. PubMed ID: 11243225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on the mitoxantrone ethylcellulose microspheres for liver artery embolization].
    Zhang ZR; Wang D; Liao FY; Liao GT
    Yao Xue Xue Bao; 1996; 31(8):626-31. PubMed ID: 9772711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [An observation of the anticarcinogenic effect of mitoxantrone-polybutylcyanoacrylate-nanosperes].
    Zhang Z; Liao G; Hou S; Bai S; Zhang X
    Hua Xi Yi Ke Da Xue Xue Bao; 1993 Dec; 24(4):381-4. PubMed ID: 8150436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-tumor effects of polybutylcyanoacrylate nanoparticles of diallyl trisulfide on orthotopic transplantation tumor model of hepatocellular carcinoma in BALB/c nude mice.
    Zhang ZM; Yang XY; Deng SH; Xu W; Gao HQ
    Chin Med J (Engl); 2007 Aug; 120(15):1336-42. PubMed ID: 17711740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on the mitoxantrone carboxymethyl starch microspheres for hepatic artery chemoembolization].
    Zhang Z; Wei Z; Wang L; Liao F
    Yao Xue Xue Bao; 1998 Oct; 33(10):772-7. PubMed ID: 12016932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on liver targeting and sustained release hydroxycamptothecin polybutylcyanoacrylate nanoparticles].
    Zhang ZR; Lu W
    Yao Xue Xue Bao; 1997; 32(3):222-7. PubMed ID: 11327027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained-release hydroxycamptothecin polybutylcyanoacrylate nanoparticles as a liver targeting drug delivery system.
    Sun X; Wu F; Lu W; Zhang ZR
    Pharmazie; 2004 Oct; 59(10):791-4. PubMed ID: 15544059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study on the anticarcinogenic effect and acute toxicity of liver-targeting mitoxantrone nanoparticles.
    Zhang ZR; He Q; Liao GT; Bai SH
    World J Gastroenterol; 1999 Dec; 5(6):511-514. PubMed ID: 11819500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on lung targeting gelatin microspheres of mitoxantrone].
    Wang JH; Lu B; Xu PL; Bao DY; Zhang ZR
    Yao Xue Xue Bao; 1995; 30(7):549-55. PubMed ID: 7484159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of diameter of adriamycin polybutylcyanoacrylate nanoparticles on liver targeting].
    Shen LF; Wang X; Wang C; Zhao K; Liu XJ; Shen HJ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 31(5):732-6, 741. PubMed ID: 17062941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute toxicity of liver targeting mitoxantrone-nanospheres].
    Zhang Z; Liao G
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Mar; 26(1):38-40. PubMed ID: 7657335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body distribution of free, liposomal and nanoparticle-associated mitoxantrone in B16-melanoma-bearing mice.
    Reszka R; Beck P; Fichtner I; Hentschel M; Richter J; Kreuter J
    J Pharmacol Exp Ther; 1997 Jan; 280(1):232-7. PubMed ID: 8996201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polybutylcyanoacrylate nanoparticles as a carrier for mitomycin C in rabbits bearing VX2-liver tumor.
    Xi-Xiao Y; Jan-Hai C; Shi-Ting L; Dan G; Xv-Xin Z
    Regul Toxicol Pharmacol; 2006 Dec; 46(3):211-7. PubMed ID: 17010489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A preliminary study on MeO-PEG-PLGA-PEG-OMe nanoparticles as intravenous carriers.
    Duan Y; Xu J; Lin Y; Yu H; Gong T; Li Y; Zhang Z
    J Biomed Mater Res A; 2008 Nov; 87(2):515-23. PubMed ID: 18186066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on liver targeted valaciclovir polybutylcyanoacrylate nanoparticles].
    Zhang Z; He Q
    Yao Xue Xue Bao; 1998 Sep; 33(9):702-6. PubMed ID: 12016876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitoxantrone-loaded BSA nanospheres and chitosan nanospheres for local injection against breast cancer and its lymph node metastases. II: Tissue distribution and pharmacodynamics.
    Lu B; Xiong SB; Yang H; Yin XD; Zhao RB
    Int J Pharm; 2006 Jan; 307(2):175-81. PubMed ID: 16314056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver targeting and the delayed drug release of the nanoparticles of adriamycin polybutylcyanoacrylate in mice.
    Shen LF; Zhang YD; Shen HJ; Zeng S; Wang X; Wang C; Le Y; Shen H
    Chin Med J (Engl); 2006 Aug; 119(15):1287-93. PubMed ID: 16919188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.